Best CRT - P Hospitals in India

Manipal Hospital, Dwarka is a trusted healthcare provider for CRT - P, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 2018, the NABH hospital is situated in Delhi, India and has 380 beds.

Cardiac Resynchronization Therapy with Pacemaker (CRT-P) can help improve the coordination of ventricular contractions in patients with heart failure and electrical conduction disorders. Unlike CRT-D, CRT-P provides resynchronization therapy without a defibrillator function. During implantation, leads are positioned in appropriate chambers of the heart and connected to a pulse generator placed beneath the skin. Comprehensive cardiac evaluation before treatment and regular device monitoring are important for effective long-term management.

Yashoda Hospital, Malakpet provides specialized CRT - P with a focus on precise device implantation, patient safety, and long-term cardiac management. Established in 1989, the NABH, NABL hospital is located in Hyderabad, India and operates 404 beds with modern cardiac infrastructure.

CRT-P is designed to provide cardiac resynchronisation by coordinating the contractions of the heart's ventricles through controlled electrical stimulation. It may be used in carefully patients with heart failure and specific electrical conduction abnormalities. Unlike a CRT-D system, CRT-P does not include an implantable defibrillator. Doctors perform detailed cardiac testing before implantation to determine suitability and plan the procedure, followed by regular device checks and cardiology follow-up to monitor therapy.

Ruby Hall Clinic is a trusted healthcare provider for CRT - P, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 1959, the NABH, NABL hospital is situated in Pune, India and has 600 beds.

Cardiac Resynchronization Therapy with Pacemaker (CRT-P) can help improve the coordination of ventricular contractions in patients with heart failure and electrical conduction disorders. Unlike CRT-D, CRT-P provides resynchronization therapy without a defibrillator function. During implantation, leads are positioned in appropriate chambers of the heart and connected to a pulse generator placed beneath the skin. Comprehensive cardiac evaluation before treatment and regular device monitoring are important for effective long-term management.

Apollo Hospitals Bannerghatta provides specialized CRT - P with a focus on precise device implantation, patient safety, and long-term cardiac management. Established in 2007, the JCI hospital is located in Bangalore, India and operates 350 beds with modern cardiac infrastructure.

CRT-P is designed to provide cardiac resynchronisation by coordinating the contractions of the heart's ventricles through controlled electrical stimulation. It may be used in carefully patients with heart failure and specific electrical conduction abnormalities. Unlike a CRT-D system, CRT-P does not include an implantable defibrillator. Doctors perform detailed cardiac testing before implantation to determine suitability and plan the procedure, followed by regular device checks and cardiology follow-up to monitor therapy.

Choosing Fortis Hospital for CRT - P gives patients access to experienced cardiologists, advanced electrophysiology technology, and comprehensive heart failure care. Established in 2001, the NABH, NABL, JCI hospital in Bangalore, India has 375 beds and provides specialized cardiac services.

CRT-P may be considered for patients whose heart failure is associated with reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The implanted device delivers electrical impulses to coordinate ventricular activity and may improve cardiac efficiency and symptoms in appropriate patients. Before implantation, doctors evaluate heart rhythm, ventricular function, symptoms, and other clinical factors. Regular follow-up helps assess device performance and ongoing heart function.

Fortis Hospital offers advanced CRT-P (Cardiac Resynchronization Therapy with Pacemaker) using modern cardiac device implantation techniques and internationally accepted treatment protocols. Established in 2011, the NABH, NABL hospital is located in Kolkata, India and has 400 beds, providing comprehensive cardiovascular care for local and international patients.

CRT-P is a device-based treatment used for patients with heart failure and abnormal electrical conduction that causes the heart's ventricles to beat out of sync. The device delivers coordinated electrical impulses to help synchronize ventricular contractions and improve cardiac efficiency. Before implantation, doctors assess heart rhythm, ventricular function, and overall cardiac health through ECG, echocardiography, and other tests. Regular follow-up helps monitor device function and the patient's response to therapy.

At Batra Hospital, CRT - P is performed using advanced cardiac electrophysiology techniques and personalized treatment plans based on the patient's condition. Established in 1987, this NABH hospital in Delhi, India has 495 beds and provides comprehensive heart rhythm care.

CRT-P may be recommended for patients with heart failure, reduced ventricular function, and electrical conduction abnormalities that result in poorly coordinated heartbeats. The device uses leads to deliver electrical stimulation to the heart's ventricles, helping improve their synchronization. Before implantation, specialists generally perform ECG, echocardiography, and other cardiac assessments to determine whether CRT-P is appropriate. Follow-up visits are important for adjusting the device and evaluating treatment response.

At Fortis Hiranandani Hospital, CRT - P is performed using advanced cardiac electrophysiology techniques and personalized treatment plans based on the patient's condition. Established in 2007, this NABH hospital in Mumbai, India has 149 beds and provides comprehensive heart rhythm care.

CRT-P may be recommended for patients with heart failure, reduced ventricular function, and electrical conduction abnormalities that result in poorly coordinated heartbeats. The device uses leads to deliver electrical stimulation to the heart's ventricles, helping improve their synchronization. Before implantation, specialists generally perform ECG, echocardiography, and other cardiac assessments to determine whether CRT-P is appropriate. Follow-up visits are important for adjusting the device and evaluating treatment response.

Choosing Jaypee Hospital for CRT - P gives patients access to experienced cardiologists, advanced electrophysiology technology, and comprehensive heart failure care. Established in 2014, the NABH, JCI hospital in Noida, India has 1200 beds and provides specialized cardiac services.

CRT-P may be considered for patients whose heart failure is associated with reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The implanted device delivers electrical impulses to coordinate ventricular activity and may improve cardiac efficiency and symptoms in appropriate patients. Before implantation, doctors evaluate heart rhythm, ventricular function, symptoms, and other clinical factors. Regular follow-up helps assess device performance and ongoing heart function.

Fortis Hospital, Shalimar Bagh provides specialized CRT - P with a focus on precise device implantation, patient safety, and long-term cardiac management. Established in 2010, the NABH hospital is located in Delhi, India and operates 262 beds with modern cardiac infrastructure.

CRT-P is designed to provide cardiac resynchronisation by coordinating the contractions of the heart's ventricles through controlled electrical stimulation. It may be used in carefully patients with heart failure and specific electrical conduction abnormalities. Unlike a CRT-D system, CRT-P does not include an implantable defibrillator. Doctors perform detailed cardiac testing before implantation to determine suitability and plan the procedure, followed by regular device checks and cardiology follow-up to monitor therapy.

Seven Hills Hospital provides specialized CRT - P with a focus on precise device implantation, patient safety, and long-term cardiac management. Established in 1986, the NABH, NABL, JCI hospital is located in Mumbai, India and operates 1500 beds with modern cardiac infrastructure.

CRT-P is designed to provide cardiac resynchronisation by coordinating the contractions of the heart's ventricles through controlled electrical stimulation. It may be used in carefully patients with heart failure and specific electrical conduction abnormalities. Unlike a CRT-D system, CRT-P does not include an implantable defibrillator. Doctors perform detailed cardiac testing before implantation to determine suitability and plan the procedure, followed by regular device checks and cardiology follow-up to monitor therapy.

Choosing Sri Ramachandra Medical Centre for CRT - P gives patients access to experienced cardiologists, advanced electrophysiology technology, and comprehensive heart failure care. Established in 1985, the JCI, NABH hospital in Chennai, India has 1800 beds and provides specialized cardiac services.

CRT-P may be considered for patients whose heart failure is associated with reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The implanted device delivers electrical impulses to coordinate ventricular activity and may improve cardiac efficiency and symptoms in appropriate patients. Before implantation, doctors evaluate heart rhythm, ventricular function, symptoms, and other clinical factors. Regular follow-up helps assess device performance and ongoing heart function.

At Apollo Spectra Hospital, CRT - P is performed using advanced cardiac electrophysiology techniques and personalized treatment plans based on the patient's condition. Established in 2012, this NABH, NABL hospital in Pune, India has 30 beds and provides comprehensive heart rhythm care.

CRT-P may be recommended for patients with heart failure, reduced ventricular function, and electrical conduction abnormalities that result in poorly coordinated heartbeats. The device uses leads to deliver electrical stimulation to the heart's ventricles, helping improve their synchronization. Before implantation, specialists generally perform ECG, echocardiography, and other cardiac assessments to determine whether CRT-P is appropriate. Follow-up visits are important for adjusting the device and evaluating treatment response.

Choosing Max Super Specialty Hospital, Shalimar Bagh for CRT - P gives patients access to experienced cardiologists, advanced electrophysiology technology, and comprehensive heart failure care. Established in 2011, the NABH, NABL hospital in Delhi, India has 402 beds and provides specialized cardiac services.

CRT-P may be considered for patients whose heart failure is associated with reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The implanted device delivers electrical impulses to coordinate ventricular activity and may improve cardiac efficiency and symptoms in appropriate patients. Before implantation, doctors evaluate heart rhythm, ventricular function, symptoms, and other clinical factors. Regular follow-up helps assess device performance and ongoing heart function.

Aakash Healthcare Super Speciality Hospital provides specialized CRT - P with a focus on precise device implantation, patient safety, and long-term cardiac management. Established in 2011, the NABH, ISO hospital is located in Delhi, India and operates 230 beds with modern cardiac infrastructure.

CRT-P is designed to provide cardiac resynchronisation by coordinating the contractions of the heart's ventricles through controlled electrical stimulation. It may be used in carefully patients with heart failure and specific electrical conduction abnormalities. Unlike a CRT-D system, CRT-P does not include an implantable defibrillator. Doctors perform detailed cardiac testing before implantation to determine suitability and plan the procedure, followed by regular device checks and cardiology follow-up to monitor therapy.